Search results for "Questionnaire"

showing 10 items of 2872 documents

Timing of quality of life improvements in psoriatic patients treated with different systemic therapies

2019

Psoriasis impacts the quality of life (QoL) by disrupting overall health and social life. Thus, the use of a QoL evaluation item is crucial in assessing a therapeutic regimen. Also, faster improvements in QoL lead to better patient compliance, but very few studies compare psoriasis traditional and biologic therapies timing. To evaluate how much different systemic therapies improve disease severity and QoL, a retrospective analysis was performed on 56 patients. Subjects were administered different drugs and their vital statistics, psoriasis area severity index (PASI) and PSOdisk were collected at baseline and after 30 days. We found a moderate correlation between PASI and PSOdisk score with …

AdultMalemedicine.medical_specialtyTime FactorsAdolescentAnti-Inflammatory AgentsDermatologySeverity of Illness IndexSocial lifeYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDisease severityQuality of lifeSurveys and QuestionnairesPsoriasisInternal medicinesystemic therapiesUstekinumabmedicineHumansPsoriasisPatient complianceAgedRetrospective StudiesSkinpsoriasiAged 80 and overTherapeutic regimenbusiness.industryBiologic therapiesAdalimumabGeneral MedicineMiddle Agedmedicine.diseasehumanitiesBiological TherapyTreatment Outcomequality of life030220 oncology & carcinogenesisCyclosporineFemaleUstekinumabDermatologic AgentsbusinessFollow-Up Studiesmedicine.drug
researchProduct

Prevalence and characterization of cardiac involvement in Hunter syndrome.

2011

To assess the prevalence of cardiovascular signs and symptoms in a large group of patients with Hunter syndrome, an X-linked metabolic disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase.The Hunter Outcome Survey was established to characterize the natural history of Hunter syndrome and to assess the response to enzyme replacement therapy. Echocardiographic and electrocardiographic examination results were available for 102 patients who were enzyme replacement therapy-naïve in the Hunter Outcome Survey (median age at examination, approximately 8 years) as of Jan 23, 2009.The most common cardiovascular finding was valve disease, which was present in 63% of patients.…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentHeart DiseasesIduronate SulfataseLeft ventricular hypertrophyElectrocardiographyYoung AdultRisk FactorsInternal medicineGermanySurveys and QuestionnairesmedicinePrevalenceHumansYoung adultChildMucopolysaccharidosis IIRetrospective Studiesbusiness.industryMetabolic disorderIduronate-2-sulfataseRetrospective cohort studyHunter syndromeEnzyme replacement therapymedicine.diseaseUnited StatesSurgeryNatural historyEchocardiographyChild PreschoolPediatrics Perinatology and Child HealthbusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy

2007

An inverse association either between depression or impaired functional status and quality of life (QoL) has been reported for cancer patients, but the independent effect of depression or depressive symptoms and of functional impairment on QoL is unclear.We investigated the prevalence of depression or depressive symptoms with the Beck Depression Inventory (BDI), the functional impairment with the ECOG-Performance-Status (ECOG-PS) and the QoL with the EORTC-QLQ-C30 questionnaire in a sample of 175 hospitalised cancer patients prior to the start of chemotherapy.Sixteen of 175 patients (9.1%) screened positive for major depression, 29 (16.6%) had mild to moderate depressive symptoms. In 11 of …

AdultMalemedicine.medical_specialtyTime FactorsAdolescentPsychometricsPsychometricsHealth StatusQuality of lifeNeoplasmsSurveys and QuestionnairesInternal medicinePrevalencemedicineHealth Status IndicatorsHumansRadiology Nuclear Medicine and imagingPsychological testingProspective StudiesKarnofsky Performance StatusProspective cohort studyLife StyleneoplasmsFatigueDepression (differential diagnoses)AgedAged 80 and overAnalysis of VarianceDepressive Disorder MajorPsychological TestsUnivariate analysisDepressionbusiness.industryBeck Depression InventoryCancerHematologyGeneral MedicineMiddle Agedmedicine.diseaseHealth SurveyshumanitiesOncologyQuality of LifePhysical therapyFemalebusinessActa Oncologica
researchProduct

Two-Year Stability of Psychosis Proneness Scales and Their Relations to Personality Disorder Traits

2000

Two-year stability of Physical Anhedonia (PhA), Perceptual Aberration (PER), and Magical Ideation (MI) scale scores and their relation to personality disorder traits were examined. Additionally, the effects of a time-lagged (prospective) versus concurrent measurement of psychosis proneness and personality disorder traits were studied to examine the specificity of MI, PER, and PhA. With a non-college-student sample (n = 404), stability for PhA was sufficiently high, but for PER and MI, stability was moderate to low. The correlations between personality disorder traits and psychosis proneness scales demonstrate that simultaneous assessment leads to a more nonspecific pattern of associations f…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentPsychometricsPsychometricsHealth Toxicology and Mutagenesismedia_common.quotation_subjectPersonality DisordersCorrelationArts and Humanities (miscellaneous)Predictive Value of TestsSurveys and QuestionnairesmedicineHumansPersonalityProspective StudiesYoung adultPsychiatrymedia_commonAnhedoniamedicine.diseaseSchizotypal personality disorderPsychosis pronenessClinical PsychologyPsychotic DisordersParanoid personality disorderFemaleDisease Susceptibilitymedicine.symptomPsychologyJournal of Personality Assessment
researchProduct

Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students.

2013

STUDY OBJECTIVE: To estimate the 12-month prevalence of cognitive-enhancing drug use. DESIGN: Paper-and-pencil questionnaire that used the randomized response technique. SETTING: University in Mainz, Germany. PARTICIPANTS: A total of 2569 university students who completed the questionnaire. MEASUREMENTS AND MAIN RESULTS: An anonymous, specialized questionnaire that used the randomized response technique was distributed to students at the beginning of classes and was collected afterward. From the responses, we calculated the prevalence of students taking drugs only to improve their cognitive performance and not to treat underlying mental disorders such as attention-deficit-hyperactivity diso…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentUniversitiesSubstance-Related DisordersPoison controlSuicide preventionSurvey methodologyYoung AdultGermanySurveys and QuestionnairesInjury preventionEpidemiologymedicinePrevalenceHumansPharmacology (medical)Effects of sleep deprivation on cognitive performancePsychiatryStudentsNootropic Agentsbusiness.industryHuman factors and ergonomicsMiddle Agedmedicine.diseaseSubstance abuseFamily medicineFemalebusinessPharmacotherapy
researchProduct

Lifetime, 5-year and past-year prevalence of homelessness in Europe: a cross-national survey in eight European nations

2019

ObjectivesTo examine the lifetime, 5-year and past-year prevalence of homelessness among European citizens in eight European nations.DesignA nationally representative telephone survey using trained bilingual interviewers and computer-assisted telephone interview software.SettingThe study was conducted in France, Ireland, Italy, the Netherlands, Poland, Portugal, Spain and Sweden.ParticipantsEuropean adult citizens, selected from opt-in panels from March to December 2017. Total desired sample size was 5600, with 700 per country. Expected response rates of approximately 30% led to initial sample sizes of 2500 per country.Main outcome measuresHistory of homelessness was assessed for lifetime, …

AdultMalemedicine.medical_specialtyTime FactorsAdolescent[SDV]Life Sciences [q-bio]prevalenceService useSociodemographic dataHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesHealth servicesYoung Adult0302 clinical medicineRisk FactorsSurveys and QuestionnairesmedicineHumans1724030212 general & internal medicine150610. No inequalitySociodemographic datahomelessnessAgedOriginal ResearchAged 80 and overbusiness.industryeuropean adult citizensEurope; homelessness; prevalence; public healthCross national surveyPublic health1. No povertyGeneral MedicineMiddle Aged3. Good healthTelephone surveyEuropeTelephone interviewSocioeconomic FactorsSample size determinationIll-Housed PersonsLinear ModelsFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePublic Healthbusiness030217 neurology & neurosurgeryDemographyBMJ Open
researchProduct

Steroids in Acute Spinal Cord Injury: All But Gone Within 5 Years.

2019

Background Spinal cord injury (SCI) is a devastating event often leading to poor neurologic outcomes. One of the most widely practiced treatments has been the administration of methylprednisolone. However, today its use has been called into question over concerns of efficacy and safety. The present study evaluated the changes in the practice of steroid administration in acute SCI among members of the National Spinal Society in Poland in comparison with the results of the survey conducted in 2013. Methods The questionnaire, comprising 5 questions, was distributed among 240 spinal surgeons, members of the Polish Society of Spinal Surgery; of these, 97 (40%) responded. The results were compare…

AdultMalemedicine.medical_specialtyTime FactorsAnti-Inflammatory AgentsSpinal cord injuryMethylprednisolone03 medical and health sciences0302 clinical medicineAge groupsSurveys and QuestionnairesMedicineHumansSurveySpinal cord injurySpinal Cord Injuriesbusiness.industryMiddle Agedmedicine.diseaseSpinal surgeryCritical appraisalNeurosurgeonsMethylprednisoloneClinical evidence030220 oncology & carcinogenesisEmergency medicineAcute spinal cord injurySurgeryFemaleSteroidsNeurology (clinical)Polandbusiness030217 neurology & neurosurgerymedicine.drugWorld neurosurgery
researchProduct

Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria

2019

Objectives: Treatment of chronic spontaneous urticaria (CSU) is based on evidence-based guidelines. However, specific patient needs and benefits from therapy have not been differentiated on the guideline level. The current study was designed to use the first part of the PBI, the PNQ, to characterize[for full text, please go to the a.m. URL]

AdultMalemedicine.medical_specialtyTime FactorsCross-sectional studyHealth StatusDermatologyDiseasePatient Care Planning030207 dermatology & venereal diseases03 medical and health sciencesSex Factors0302 clinical medicineCost of IllnessQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansChronic UrticariaDisease burdenChronic urticariaAgedbusiness.industryPruritusPatient PreferenceGuidelineMiddle Aged610 Medical sciences; MedicineCross-Sectional StudiesPatient burden030228 respiratory systemddc: 610Quality of LifeItchingFemalemedicine.symptombusinessDecision Making SharedNeeds Assessment
researchProduct

Initial Evaluation of a Smoking Cessation Program Incorporating Physical Activity Promotion to Greek Adults in Antismoking Clinics

2012

The purpose of this study was to evaluate an initial application of a smoking cessation program that integrated the promotion of physical activity (PA) as a cessation aid to Greek adults in antismoking clinics. From an initial pool of 50, 12 men and 28 women from Central Greece completed the program, and 18 of them succeeded in quitting for 1 year after the program. Additionally, after the program, they increased their PA. Suggestions for future applications of the program are further discussed. peerReviewed

AdultMalemedicine.medical_specialtyTime FactorsPsychometricsPsychometricsmedia_common.quotation_subjectmedicine.medical_treatmentMEDLINEPhysical activityAlternative medicineDirective Counselingphysical activityPilot ProjectsGreek adultsHealth PromotionMotor ActivityPromotion (rank)Surveys and QuestionnairesAmbulatory CaremedicineHumansta315media_commonGreecebusiness.industryHealth PolicyMiddle AgedPeer reviewsmoking cessationcounselingFamily medicinePhysical therapySmoking cessationFemaleSmoking CessationbusinessarviointiProgram Evaluation
researchProduct

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression

2009

Abstract Background There is substantial evidence that early improvement (EI) under antidepressant treatment is a clinically useful predictor of later treatment outcome in patients with major depressive disorders. The aim of this study was to test whether EI can also be used as a predictor for treatment outcome in patients with mild major, minor or subsyndromal depression, i.e. patients, who are typically treated by general practitioners. Methods Analyses were carried out using data from 223 patients of a 10-weeks randomized, placebo-controlled trial comparing the effectiveness of sertraline and cognitive-behavioural therapy (CBT) in patients with mild major, minor or subsyndromal depressio…

AdultMalemedicine.medical_specialtyTime FactorsSeverity of Illness Indexlaw.inventionRandomized controlled trialPredictive Value of TestslawSertralineSurveys and QuestionnairesInternal medicineSeverity of illnessmedicineHumansProspective StudiesPsychiatryProspective cohort studyDepression (differential diagnoses)Depressive DisorderDepressive Disorder MajorSertralineCognitive Behavioral TherapyHamilton Rating Scale for DepressionCombined Modality TherapyAntidepressive AgentsConfidence intervalPsychiatry and Mental healthClinical PsychologyTreatment OutcomePredictive value of testsFemalePsychologymedicine.drugJournal of Affective Disorders
researchProduct